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Developmental neurobiology: A genetic Cheshire cat?
Jerold Chun
In the wake of evidence that essential neurogenic
processes might involve aspects of DNA rearrangement,
recent discoveries about the unusual arrangement
of genes encoding neuronal adhesion molecules known
as protocadherins are very intriguing. But is this just
a coincidence?
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“Curiouser and curiouser!” Alice’s reaction to the strange
events encountered during her Adventures in Wonderland is
being echoed by biologists puzzling over recent tantaliz-
ing hints that somatic DNA rearrangement — of a kind
well-known to be of fundamental importance in the
immune system — may operate in the nervous system.
The first of these hints, reviewed recently in these pages
[1], came from close examination of mutant mice deficient
for components of the enzymatic machinery essential for
the DNA rearrangements that create the genes for mature
antigen receptors of B and T lymphocytes. These mutant
mice, deficient for either DNA ligase IV [2,3] or its
dimerization partner XRCC4 [2], were found to exhibit a
striking increase in the death of very young neurons and
neuroblasts. This phenotype has subsequently been
found to be shared by mice deficient in other components
of the so-called ‘non-homologous end-joining system’ (F.
Alt, personal communication). 
These results have excited interest in the possibility that
some form of somatic DNA rearrangement might be
associated with the development of the nervous system,
although this is certainly not the only explanation for the
observations. If DNA rearrangement does turn out to be
important in the nervous system, what are the relevant
genetic targets? Such a target is, of course, likely to be
expressed in the nervous system, probably in specific sub-
populations of neurons; by analogy with the antigen-
receptor genes, it is likely to consist of a large gene family,
and the genes might well encode cell-surface molecules
[4]. An attractive candidate target that fits these criteria
has been identified. This is the family of genes encoding
the protocadherins [5–7], a subfamily of the cadherin
adhesion molecules. The protocadherin genes in humans
have recently been found [8] to have a genomic structure
that is rather suggestive of a locus that might undergo
DNA rearrangements.
Protocadherins and cadherin-related neuronal receptors
The protocadherins are structurally related to the better-
known ‘classical cadherins’ [9] (Figure 1). These are cell
adhesion molecules that engage in calcium-dependent
homophilic interactions, and have been shown to have
important roles in development. They are oriented in the
membrane with the amino-terminus outside the cell; the
amino-terminal signal peptide is followed by a characte-
ristic grouping of five tandem repeats, known as
‘ectodomains’, a single transmembrane region, and then
an intracellular carboxy-terminal region that interacts with
the cytoskeleton. Protocadherins have a similar extracellu-
lar organization, with five or six ectodomains, but they
clearly differ in the cytoplasmic region.
A distinct subgroup related to the protocadherins consists
of the cadherin-related neuronal receptors [7]. These all
have six ectodomains — the first of which has an unusual
RGD (putative integrin-binding) motif — and a distinc-
tive cytoplasmic region that includes a characteristic
lysine-rich segment. Notably, the cadherin-related neu-
ronal receptors and some protocadherins show enriched or
specific expression in the nervous system [7,10]; and like
some of the classical cadherin subtypes, the cadherin-
related neuronal receptors can also show differential
expression in subpopulations of synapses [11].
The Cnr genes that encode the cadherin-related neuronal
receptors were first cloned on the basis of their protein
products’ ability to bind to the tyrosine kinase Fyn, a
molecule that has been shown to function in both the
immune system — where it is involved in signaling from
the T-cell receptor [12] — and the nervous system — fyn
deletion has been associated with behavioral deficits [13].
The mouse Cnr genes were initially found [7] to be part of
a multi-gene family, with the additional interesting
feature that when genomic DNA was hybridized with a 5′
Cnr cDNA probe, approximately 20 different genes were
recognized, whereas a 3′ Cnr cDNA probe detected only
three or so genes. This indicated that the 5′ coding portion
of the Cnr cDNA may have originated from a diverse
locus, whereas the 3′ portion had a simpler and clearly dif-
ferent genomic origin. This observation was further
remarkable in that multiple Cnr genes appeared to reside
in the same chromosomal region, suggesting a rather local-
ized and perhaps tandem gene organization, and hinting at
interesting mechanisms of gene regulation, likely includ-
ing mRNA splicing or even DNA rearrangement.
Organization of human protocadherin genes
Wu and Maniatis [8] have now analysed the human coun-
terpart of the protocadherin genes, including the Cnrs. By
a combination of genomic database analyses and cDNA
cloning, they identified a multigene family, subgroups of
which encoded proteins homologous to the mouse proto-
cadherins and cadherin-related neuronal receptors. They
identified approximately 52 genes, spread over nearly
700 kilobases of the genome (Figure 2a). Within this
locus, which was mapped to chromosome 5q31, three sub-
families of ‘protocadherin human’ (Pcdh) genes — α, β and γ
— were identified.
Most remarkable was the organization of genes within
each subfamily. In the 5′ — upstream — part of each
group, multiple, homologous ‘variable’ gene segments
were  found to be tandemly arrayed. The last of these was
followed by three small exons encoding a single constant
region, the cytoplasmic portion of the protein. The con-
stant regions encoded by Pcdhα and Pcdhγ differ in
sequence; for Pcdhβ, the constant region exons have not
yet been identified, but it seems likely that they will
eventually be found. Each variable gene segment
encoded the remaining — extracellular and transmem-
brane — domains of the protocadherin. At some level —
RNA splicing or DNA recombination — the coding
sequences of the variable segment and the constant
region exons are joined, so that the final mRNA encodes a
full protocadherin protein. This organization can explain
why, in the mouse, a 5′ Cnr probe recognized a much
larger group of gene segments than a 3′ Cnr probe. It is
quite different from the more conventional organization
of the genes encoding the classical cadherins, such as
P-cadherin or L-CAM [14]. 
Similarities to antigen receptor genes
This general organization of tandemly arranged gene
segments is reminiscent of the distributed germline
organization of antigen receptor genes (Figure 2b). So far,
physiological somatic DNA rearrangements have been
demonstrated only in the immune system, where they
bring together the gene segments needed to produce
mature genes coding for immunoglobulin heavy and light
chains [15] and the T-cell receptor [16]. In the immune
system, this process of recombination generates the huge
diversity of receptors needed to guard against similarly
diverse foreign antigens. Taking the immunoglobulin
heavy chain locus as an example, the component segments
— V (‘variable’), D (‘diversity’) and J (‘joining’) — are
brought together by specific ‘V(D)J recombination’ reac-
tions; multiple exons coding for the protein’s constant
region domains are located downstream of the J segments
[17]. V(D)J recombination requires cis elements, known as
‘recognition signal sequences’, and the specific recombi-
nase proteins, Rag1 and Rag2 [18]. 
A number of the key hallmarks of V(D)J recombination are
clearly not shared by the protocadherin loci. The entire
protocadherin variable region is encoded by a single exon,
so any genetic rearrangement must involve joining of a
variable gene segment to the constant region exons. In the
case of the antigen receptor genes, this particular joining
event involves either splicing or a non-site-specific DNA
rearrangement (see below). Any sequences significantly
similar to the recognition signal sequences of the antigen
receptor genes should have been recognizable; Wu and
Maniatis [8] did not find any such sequences within the
protocadherin loci, though as they noted this does not rule
out the presence of a different type of cis-acting recogni-
tion sequence for recombination. 
The possibility that a site-specific DNA rearrangement of
the kind that occurs in the immune system operates at the
protocadherin loci is thus a remote one. As alternatives,
Wu and Maniatis [8] have suggested three different types
of RNA splicing mechanism that could bring together the
protocadherin coding sequences. As an aside, it seems
likely, given the availability of DNA sequence data and
the sophistication of polymerase chain reaction (PCR)
techniques, that any obvious rearrangement at the
protocadherin loci would have already been identified.
Given these considerations, are there any other aspects of
protocadherin genes suggestive of DNA rearrangement?
Gene rearrangement?
Several intriguing aspects of the protocadherins remain
for one to ponder. First, the cadherin-related neuronal
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Figure 1
An outline of the domain organization of cadherins (left) and protocadherins
or cadherin-related neuronal receptors (right). (See text for details.)
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receptors — generally considered a subfamily of the pro-
tocadherins — were first identified by their ability to bind
Fyn, which in the immune system interacts with the
product of genes that clearly undergo DNA rearrange-
ment — the T-cell receptor [12]. Second, earlier studies
suggested that, if DNA rearrangement does occur in the
nervous system, it would be of a distinct kind from V(D)J
recombination, as although Rag1 has been observed in
neurons the requisite Rag2 has not [1,19,20]. And third,
the genomic organization of the protocadherin loci —
with a tandem array of intact variable exons, rather than
multiple gene segments that require joining to create
complete exons — itself suggests that any kind of DNA
rearrangement would be significantly different from
V(D)J recombination. 
Another type of DNA recombination that operates on the
immunoglobulin heavy chain gene is that mediating ‘class
switching’ [21]. Following V(D)J recombination, produc-
tion of a heavy chain protein involves RNA splicing that
joins the variable region exons to either µ or δ constant
region exons; subsequent maturation of the B cell bearing
the immunoglobulin involves switching to production of a
different type of heavy chain, typically an immunoglobulin
G with a constant region encoded by γ exons. This class
switching involves DNA rearrangement that is not site-
specific. Another type of DNA rearrangement, known for
many years as the basis of yeast mating-type switching, but
likely to occur in other contexts (such as the chicken
immune system), is gene conversion [22]. This process
also is not site-specific, but exploits sequence similarity
within tandem gene arrays — a condition that does exist at
the protocadherin loci. 
A very speculative possibility is that one or other, or both,
of these mechanisms might be used to produce different
combinations of variable and constant exons, and thereby
recombining the extracellular adhesion and intracellular
signaling specificities in different ways. In the nervous
system, where neurons can be very long-lived, a genomic
alteration may provide advantages over a reliance on non-
genomic ways of controlling gene expression. Classical
cadherins interact homophilically. How protocadherins
interact in vivo is unclear, but combining extracellular and
intracellular domains in different ways could achieve a
substantial degree of combinatorial complexity that could
be very useful for the nervous system.
All of these musings lead back to the original problem of
identifying a rearrangement locus. It might prove fruitful
to investigate whether non-homologous end joining is rel-
evant to protocadherin expression, though it should be
noted that deficiency of XRCC4 or DNA ligase IV [2,3]
causes neuronal death and embryonic lethality, whereas
deficiency of Fyn, which signals downstream of the cad-
herin-related neuronal receptors at least, causes non-lethal
behavioral abnormalities [11]. One could, however,
imagine that protocadherins interact with a range of other
intracellular signaling molecules that can partially rescue
the Fyn deficiency, but not the more pervasive defects
caused by a loss of non-homologous end joining capacity.
If protocadherin genes do undergo DNA rearrangement, it
should not take long to demonstrate the fact. One should
not be too surprised, however, if strange beasts still remain
to be encountered. 
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Figure 2
A comparison of the genomic organization of (a) protocadherin loci [8]
and (b) an immunoglobulin heavy chain locus. (See text for details.)
α β γ
Variable exons Constantexons
Variable region Constant region
(15 + 3) (15 + ?) (22 + 3)
5′
(a) Protocadherin loci
(b) Immunoglobulin heavy chain locus
Variable exons Constant exons
Variable region
  Current Biology
Constant
region
V D J C
(Many 100s) (20) (4)
V D J
5′
(8)
Constant region
class switch
V D J
Cµ
Cγ
References
1. Chun J, Schatz DG: Developmental neurobiology: alternative
“ends” to a familiar story? Curr Biol 1999, 9:R251-R253.
2. Gao Y, Sun Y, Frank KM, Dikkes P, Fujiwara Y, Seidl KJ, Sekiguchi JM,
Rathbun GA, Swat W, Wang J, et al.: A critical role for DNA end-
joining proteins in both lymphogenesis and neurogenesis. Cell
1998, 95:891-902.
3. Barnes DE, Stamp G, Rosewell I, Denzel A, Lindahl T: Targeted
disruption of the gene encoding DNA ligase IV leads to lethality in
embryonic mice. Curr Biol 1998, 8:1395-1398.
4. Dreyer WJ, Gray WR, Hood L: The genetic, molecular and cellular
basis of antibody formation: some facts and a unifying
hypothesis. Cold Spring Harbor Symp Quant Biol 1967,
32:353-367.
5. Obata S, Sago H, Mori N, Rochelle JM, Seldin MF, StJohn T,
Taketani S, Suzuki ST: Protocadherin Pcdh2 shows properties
similar to, but distinct from, those of classical cadherins. J Cell Sci
1995, 108:3765-3773.
6. Sago H, Kitagawa M, Obata S, Mori N, Taketani S, Rochelle JM,
Seldin MF, Davidson M, StJohn T, Suzuki ST: Cloning, expression,
and chromosomal localization of a novel cadherin-related protein,
protocadherin-3. Genomics 1995, 29:631-640.
7. Kohmura N, Senzaki K, Hamada S, Kai N, Yasuda R, Watanabe M,
Ishii H, Yasuda M, Mishina M, Yagi T: Diversity revealed by a novel
family of cadherins expressed in neurons at a synaptic complex.
Neuron 1998, 20:1137-1151.
8. Wu Q, Maniatis T: A striking organization of a large family of
human neural cadherin-like cell adhesion genes. Cell 1999,
97:779-790.
9. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic
regulator. Science 1991, 251:1451-1455.
10. Hirano S, Yan Q, Suzuki ST: Expression of a novel protocadherin,
OL-protocadherin, in a subset of functional systems of the
developing mouse brain. J Neurosci 1999, 19:995-1005.
11. Yagi T: Molecular mechanisms of Fyn-tyrosine kinase for
regulating mammalian behaviors and ethanol sensitivity. Biochem
Pharmacol 1999, 57:845-850.
12. Samelson LE, Phillips AF, Luong ET, Klausner RD: Association of the
fyn protein-tyrosine kinase with the T-cell antigen receptor. Proc
Natl Acad Sci USA 1990, 87:4358-4362.
13. Grant SG, O’Dell TJ, Karl KA, Stein PL, Soriano P, Kandel ER:
Impaired long-term potentiation, spatial learning, and
hippocampal development in Fyn mutant mice. Science 1992,
258:1903-1910.
14. Hatta M, Miyatani S, Copeland NG, Gilbert DJ, Jenkins NA, Takeichi
M: Genomic organization and chromosomal mapping of the
mouse P-cadherin gene. Nucleic Acids Res 1991, 19:4437-4441.
15. Hozumi N, Tonegawa S: Evidence for somatic rearrangements of
immunoglobulin genes coding for variable and constant regions.
Proc Natl Acad Sci USA 1976, 73:3628-3632.
16. Hedrick SM, Cohen DI, Nielsen EA, Davis MM: Isolation of cDNA
clones encoding T cell-specific membrane-associated proteins.
Nature 1984, 308:149-153.
17. Alt F, Yancopoulos GD, Blackwell TK, Wood C, Thomas E, Boss M,
Coffman R, Rosenberg N, Tonegawa S, Baltimore D: Ordered
rearrangement of immunoglobulin heavy chain variable region
segments. EMBO J 1984, 3:1209-1219.
18. Schatz DG: V(D)J recombination moves in vitro. Semin Immunol
1997, 9:149-159.
19. Chun JJ, Schatz DG, Oettinger MA, Jaenisch R, Baltimore D: The
recombination activating gene-1 (RAG-1) transcript is present in
the murine central nervous system. Cell 1991, 64:189-200.
20. Chun J, Schatz D: Rearranging views on neurogenesis: neuronal
death in the absence of DNA end-joining proteins. Neuron 1999,
22:7-10.
21. Lutzker SG, Alt FW: Immunoglobulin heavy-chain class switching.
In Mobile DNA. Edited by Berg DE, Howe MM. Washington, DC:
American Society for Microbiology; 1989:693-714. 
22. Carlson LM, Oettinger MA, Schatz DG, Masteller EL, Hurley EA,
McCormack WT, Baltimore D, Thompson CB: Selective expression
of RAG-2 in chicken B cells undergoing immunoglobulin gene
conversion. Cell 1991, 64:201-208.
R654 Current Biology, Vol 9 No 17
If you found this dispatch interesting, you might also want
to read the August 1999 issue of
Current Opinion in
Genetics & Development
which included the following reviews, edited
by Norbert Perrimon and Claudio Stern,
on Pattern formation and developmental
mechanisms:
Cell polarity in the early Caenorhabditis elegans
embryo
Bruce Bowerman and Christopher A Shelton
The polarisation of the anterior–posterior and
dorsal–ventral axes during Drosophila oogenesis
Fredericus van Eeden and Daniel St Johnston
Wnt signaling and dorso–ventral axis specification
in vertebrates
Sergei Y Sokol
Establishment of anterior–posterior polarity in
avian embryos
Rosemary F Bachvarova
Polarity in early mammalian development
Richard L Gardner
Diverse initiation in a conserved left–right pathway?
H Joseph Yost
Extracellular modulation of the Hedgehog, Wnt,
and TGF-β signalling pathways during embryonic
development
Javier Capdevila and Juan Carlos Izpisúa Belmonte
Fringe, Notch, and making developmental boundaries
Kenneth D Irvine
Polarity determination in the Drosophila eye
Helen Strutt and David Strutt
Wnt signalling: pathway or network?
Alfonso Martinez Arias, Anthony MC Brown
and Keith Brennan
Epithelial cell movements and interactions in limb,
neural crest and vasculature
Cheryll Tickle and Muriel Altabef
Cell movement in the sea urchin embryo
Charles A Ettensohn
Cell migration in Drosophila
Alexandria Forbes and Ruth Lehmann
The full text of Current Opinion in Genetics &
Development is in the BioMedNet library at
http://BioMedNet.com/cbiology/gen
